For: | Tan CK, Ho D, Wang LM, Kumar R. Drug-induced autoimmune hepatitis: A minireview. World J Gastroenterol 2022; 28(24): 2654-2666 [PMID: 35979160 DOI: 10.3748/wjg.v28.i24.2654] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i24/2654.htm |
Number | Citing Articles |
1 |
Caitlin E. Kulig, Jessica Wilczynski, Jami Zajicek. . Side Effects of Drugs Annual 2023; 45: 427 doi: 10.1016/bs.seda.2023.07.009
|
2 |
Ana Paula Madariaga-Traconis, Mirna Daniela Gamez-Castro, Varenka Julieta Barbero-Becerra. El papel de los anestésicos en el daño hepático. Revista Mexicana de Anestesiología 2025; 48(2): 98 doi: 10.35366/119203
|
3 |
Hao Chen, Lan-Lan Li, Yan Du. Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1115226
|
4 |
Mitwa Patel, Abdul Fattah, Helai Hussaini, Fnu Maneesha, Zahoor Ahmed. Drug-Induced Autoimmune Hepatitis: An Unusual Adverse Event of Atorvastatin Therapy. Cureus 2024; doi: 10.7759/cureus.55809
|
5 |
Chen Pan, Xiaozhu Zhou, Yu Wang, Yi Wu, Qiang Han, Xiangli Cui. Autoimmune hepatitis associated with statins: a retrospective study of pharmacovigilance databases and review of the literature. Expert Opinion on Drug Safety 2025; : 1 doi: 10.1080/14740338.2025.2449986
|
6 |
Bu-kun Zhu, Si-ying Chen, Xiang Li, Shu-yun Huang, Zhan-yang Luo, Wei Zhang. Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-89272-x
|
7 |
Samannay Das, Vikrant Sood, Archana Rastogi, Neha Agarwal, Sanjeevani Kaul, Deepika Yadav, Bikrant Bihari Lal, Rajeev Khanna, Seema Alam. Clinico‐Pathological Spectrum of Hepatitis A Virus‐Induced Autoimmune‐Like Hepatitis in Children. Journal of Viral Hepatitis 2025; 32(4) doi: 10.1111/jvh.14028
|
8 |
Rolf Teschke. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. International Journal of Molecular Sciences 2023; 24(7): 6663 doi: 10.3390/ijms24076663
|
9 |
Doaa I. Mohamed, Hebatallah H. Abo Nahas, Asmaa M. Elshaer, Dalia Alaa El-Din Aly El-Waseef, Omnyah A. El-Kharashi, Soha M. Y. Mohamed, Yasmine Gamal Sabry, Riyad A. Almaimani, Hussain A. Almasmoum, Abdulmalik S. Altamimi, Ibrahim Abdel Aziz Ibrahim, Samar Z. Alshawwa, Mariusz Jaremko, Abdul-Hamid Emwas, Essa M. Saied. Unveiling the interplay between NSAID-induced dysbiosis and autoimmune liver disease in children: insights into the hidden gateway to autism spectrum disorders. Evidence from ex vivo, in vivo, and clinical studies. Frontiers in Cellular Neuroscience 2023; 17 doi: 10.3389/fncel.2023.1268126
|
10 |
Sonali Kochhar, David N. Assis, Cara Mack, Hector S. Izurieta, Luigi Muratori, Alma Munoz, Dale Nordenberg, Jane F. Gidudu, Erin F. Blau, John M. Vierling. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine 2024; 42(7): 1812 doi: 10.1016/j.vaccine.2024.01.021
|
11 |
Yu-Ting Xiong, Jian-Fei Wang, Le Li, Zhi-Fang Bai, Yan Liu, Ang Huang, Ke-Xin Wang, Yiming Fu, Wucai Yang, Chang Guo, Mengwen He, Wen-Chang Wang, Chun-Yan Wang, Dong Ji. Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury. iLIVER 2024; 3(2): 100095 doi: 10.1016/j.iliver.2024.100095
|
12 |
Dieudonne Nonga, Maria Amendola, Jordan Serio, Mary Ayers, Amy Taylor, James E. Squires. Pediatric Autoimmune Hepatitis. Current Treatment Options in Pediatrics 2023; 9(3): 106 doi: 10.1007/s40746-023-00271-4
|
13 |
Raúl Fabrizio Manchamé-Moreno, Christyan Arturo Borrayo-Alvarado. Hepatitis autoinmune inducida por drogas: asociación con nitrofurantoína. Revista Española de Casos Clínicos en Medicina Interna 2024; 9(3): 130 doi: 10.32818/reccmi.a9n3a8
|
14 |
Ammad Javaid Chaudhary, Muhammad Zarrar Khan, Abdullah Sohail, Syed Murtaza Haider Zaidi, Eric Denha, Deepak Venkat. Acute onset nitrofurantoin‐induced autoimmune hepatitis after urinary tract infection treatment. Clinical Case Reports 2024; 12(6) doi: 10.1002/ccr3.9050
|
15 |
Rolf Teschke. Treatment of Drug-Induced Liver Injury. Biomedicines 2022; 11(1): 15 doi: 10.3390/biomedicines11010015
|
16 |
Jonathan Tse, Sam Natla, Rohit Mekala, Ian Crumm, Melissa H Olken. Atorvastatin-Induced Autoimmune Hepatitis: A Case Report. Cureus 2023; doi: 10.7759/cureus.47807
|
17 |
Jawaher J. Alotaibi, Bushra Albuqami, Wadha Alotaibi, Rawan M. Al Ghamdi, Mohammed Alaskar, Hadi Kuriry, Nasser Almasri. Denosumab‐induced autoimmune hepatitis: Case report. Clinical Case Reports 2024; 12(4) doi: 10.1002/ccr3.8736
|
18 |
Rolf Teschke, Gaby Danan. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use. International Journal of Molecular Sciences 2023; 24(13): 10855 doi: 10.3390/ijms241310855
|
19 |
Yang Zhang, Dehe Zhang, Ling Chen, Jing Zhou, Binbin Ren, Haijun Chen. The progress of autoimmune hepatitis research and future challenges. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0823
|
20 |
Rolf Teschke, Gaby Danan. Idiosyncratic DILI and RUCAM under One Hat: The Global View. Livers 2023; 3(3): 397 doi: 10.3390/livers3030030
|
21 |
|
22 |
Daisy Carolina Huertas Martinez, Guilherme Andrade Bulbol, Poliana Corrêa Moreira Braga, Moisés Abtibol Machado. AVALIAÇÃO CLÍNICA DA DOENÇA DE CROHN COM SOBREPOSIÇÃO À HEPATITE AUTOIMUNE: RELATO DE CASO. Revista Contemporânea 2024; 4(1): 4934 doi: 10.56083/RCV4N1-271
|
23 |
Branislava Raičević, Ivana Stević, Dragana Lakić, Agnes Männik, Kalina Gjorgjievska, Bojan Labachevski, Kristina Pavlovska, Miodrag Žunić, Petya Milushewa, Guenka Petrova, Dominik Grega, Przemysław Holko, Slobodan M. Janković. Costs of treating serious adverse effects of drugs used for treatment of obesity: comparison of selected European countries. Biotechnology & Biotechnological Equipment 2024; 38(1) doi: 10.1080/13102818.2024.2422546
|
24 |
Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang, Zhen Liu, Cheung Kenneth Chat Pan. Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. PLOS ONE 2025; 20(2): e0317680 doi: 10.1371/journal.pone.0317680
|
25 |
Rolf Teschke. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Livers 2025; 5(1): 8 doi: 10.3390/livers5010008
|